← All indications
Pneumonia, Pneumococcal
A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.
Drugs by status
Approved for this indication (2)
Phase 4 trials (10)
Phase 3 trials (3)
Phase 2 trials (7)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (25)
- PPD
- Merck
- Pfizer
- GlaxoSmithKline
- University of London
- Hospital Mutua de Terrassa
- Korea University
- Kameda Medical Center
- Minsk State Clinical Hospital No 9
- Osaka University
- Peking University
- University of Colorado, Denver
- Belarusian State Medical University
- University of Oxford
- Government of China
- Wellcome Trust
- China National Biotec Group Co., Ltd
- Changchun Institute of Biological Products Co., Ltd.
- Fondo de Investigacion Sanitaria
- Kenya Ministry of Health
- Government of Vietnam
- Chengdu Institute of Biological Products Co.,Ltd.
- University of Nagasaki
- Murdoch University
- University of Helsinki
Organization Involved with Phase 3 Indications (4)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (5)